MSCA-DN PhD in zebrafish models for leukodystrophies (York, UK)

SIGRA

Amsterdam

On-site

EUR 57,000 - 62,000

Full time

14 days+
Application generator

Stand out for this role — generate a tailored resume and cover letter in about a minute.

Get past ATS filters

Job summary

University of York invites applications for a POLARIS doctoral position focusing on developing and standardising robust preclinical outcome measures across zebrafish models of leukodystrophy. You will collaborate across POLARIS partners, gain secondments, and work with cutting‑edge imaging modalities such as MRI and confocal microscopy.

English fluency and a strong translational neuroscience interest are essential.

Qualifications

  • Master’s degree in life sciences or related field.
  • Experience with microscopy and image-data analysis.
  • Experience with in vivo zebrafish models.
  • Experience with animal research and welfare principles.
  • Interest in developing imaging analysis pipelines using innovative approaches.

Skills

Master’s degree in life sciences
Imaging data analysis
Zebrafish models
Animal research & welfare
Coding / quantitative image analysis
GA3 Elements
English communication

Education

Master’s degree in life sciences

Tools

GA3 Elements

Job description

Develop robust preclinical outcome measures in zebrafish models of leukodystrophies. Combine behavioural studies and advanced imaging to improve disease modelling and bridge the gap between experimental findings and clinically meaningful outcomes.

POLARIS doctoral network

POLARIS is a European Marie Skłodowska-Curie Doctoral Network focused on accelerating therapy development for leukodystrophies: rare genetic disorders affecting the brain’s white matter. The network aims to strengthen the full translational pathway, from understanding disease mechanisms and developing disease models to preclinical therapy testing, clinical readiness and patient-informed treatment priorities.

To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient engagement, and ethical, regulatory and health-economic aspects of therapy development. The network will train a cohort of doctoral candidates in an international and interdisciplinary environment, combining academic research, industry-based preclinical development, secondments, network-wide training and transferable-skills development.

PhD project

For this position, the recruiting organisation is the University of York, UK. The selected candidate will be employed by the University of York and become part of the POLARIS consortium, with academic supervision and disease-specific expertise provided by Dr Noémie Hamilton at the York Biomedical Research Institute and the Department of Biology at the University of York.

You will focus on developing and standardising robust preclinical outcome measures across multiple zebrafish models of leukodystrophy, including models of RNASET2 deficiency, adrenoleukodystrophy (ALD), Krabbe disease and metachromatic leukodystrophy (MLD).

Zebrafish are widely used to model leukodystrophies because of their genetic tractability and the ability to study early brain development. To strengthen their use as preclinical models, this project will develop outcome measures that are robust, reproducible and relevant to assessments used in patients and mammalian disease models.

Your research will combine different approaches to:

  • Develop and standardise behavioural assays across multiple zebrafish models of leukodystrophy.
  • Characterise disease phenotypes using multimodal imaging and complementary experimental approaches.
  • Apply advanced imaging techniques, including MRI, high-resolution confocal microscopy and electron microscopy.
  • Develop and refine imaging analysis pipelines, using appropriate software, quantitative approaches and innovative analytical methods.
  • Compare and benchmark preclinical outcomes across different disease models and against clinically relevant measures.
  • Identify robust and reproducible readouts that can support the use of zebrafish in preclinical therapy development.
  • Work collaboratively across different research environments, integrating findings from zebrafish models with data from mammalian models and other experimental systems.

As part of the POLARIS training programme, you will undertake planned secondments that complement your research at the University of York.

At Zantiks, you will gain hands‑on experience with behavioural analysis equipment and software and learn how ideas emerging from academic research can be developed towards commercial application.

You will also undertake a secondment at the University of Liverpool’s Centre for Preclinical Imaging, a leading preclinical imaging centre with access to advanced technologies including MRI, PET, CT, SPECT, ultrasound, photoacoustic imaging, magnetic particle imaging (MPI), optical imaging and hyperthermia. These technologies can be applied across a range of experimental models, including cells, organoids, Drosophila, zebrafish and rodents.

The academic research and PhD defence will be based at the Department of Biology at the University of York.

We are looking for a motivated candidate with a strong interest in translational neuroscience, rare disease research and the development of robust preclinical models. You bring:

  • A Master’s degree in life sciences or a related field.
  • Experience with microscopy and image-data analysis, ideally gained through research projects or internships involving in vivo zebrafish models.
  • Experience with behavioural or neurological phenotyping is advantageous.
  • Experience with animal research, animal‑welfare principles and robust experimental design is advantageous.
  • An interest in developing imaging analysis pipelines using innovative or novel approaches.
  • Experience with coding, specific imaging software such as GA3 Elements, machine learning or quantitative image analysis is advantageous.
  • A strong interest in understanding how preclinical readouts can be aligned with clinically meaningful endpoints.
  • A willingness to work with researchers using different disease models and to use these models to benchmark and develop your assays.
  • A curious and critical mindset, with the ability to evaluate experimental approaches and interpret complex datasets.
  • An accurate and reproducible approach to research, with strong attention to detail and the ability to plan and organise complex experimental work.
  • Good communication and collaboration skills, with the ability to work across different research environments and disciplines.
  • The ability and willingness to work in an international and interdisciplinary research environment, collaborating with colleagues at the University of York and across the POLARIS consortium.

Fluency in English, both written and spoken, is essential.

As part of your appointment, you will complete the required UK Home Office training and certification to work with animals in accordance with UK regulations.

Eligibility criteria

Important, strict eligibility criteria according to MARIE SKLODOWSKA CURIE programs apply to applicants:

  1. You must not already hold a doctoral degree.
  2. At the time of the application deadline, you must have a Master’s degree and must not have resided or carried out your main activity (work, studies, etc.) in the UK for more than 12 months in the three years prior to the contract start date.
  3. You must be able and willing to work in an international training network, participate in network‑wide training activities and undertake planned secondments with POLARIS partner organisations.
  • A 12-month contract, with the intention to extend to a total duration of three years.
  • A salary of £48,780-£53,680, with salary, mobility allowance and benefits according to the applicable MSCA Doctoral Network and host‑organisation rules.
  • The position at the University of York is subject to standard UK right‑to‑work and visa regulations.
  • Embedding in the international POLARIS doctoral training network.
  • Access to network‑wide training activities, secondments and transferable‑skills development.
  • A challenging and translational research project at the interface of in vivo disease modelling, leukodystrophy biology, behavioural phenotyping and advanced imaging.
  • An open, supportive and positive team culture with opportunities for scientific and professional development.
  • A collaborative and interdisciplinary working environment.

See for more information: Statement of Main Terms and Conditions of Employment for Marie Curie Experienced Researchers.

The Department of Biology at the University of York, UK is internationally recognised for its research across the life sciences, including biomedical research conducted through the York Biomedical Research Institute.

You will join a supportive and collaborative research environment where you can develop your expertise and learn new techniques. The department is committed to creating an inclusive and supportive culture in which staff and students can contribute fully and develop their scientific careers.

Your research will be supervised by Dr Noémie Hamilton, based at the York Biomedical Research Institute and the Department of Biology.

The application deadline is 5 October 2026. We aim to select a final candidate in October/November 2026.

Applicants may, where appropriate and in line with the recruitment procedure, also be considered for other POLARIS doctoral candidate positions that better match their profile and interests. You can highlight up to two additional POLARIS projects of interest in your application letter. This does not replace your application to the primary position, but helps the consortium identify potential alternative matches where relevant.

For substantive information about this PhD position, please contact Dr Noémie Hamilton via noemie.hamilton@york.ac.uk.

Acquisition in response to this vacancy will not be considered.

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

MSCA-DN PhD in zebrafish models for leukodystrophies (York, UK)
MSCA-DN PhD in zebrafish models for leukodystrophies (York, UK)

Amsterdam UMC • Netherlands

On-site
EUR 57,000 - 62,000
MSCA-DN PhD in lipid nanoparticle gene therapy for leukodystrophies (London, UK)
MSCA-DN PhD in lipid nanoparticle gene therapy for leukodystrophies (London, UK)

SIGRA • Amsterdam

On-site
EUR 30,000 - 42,000
Salary and mobility allowance
Network-wide training and secondments
International collaboration
MSCA-DN PhD position in translational in vivo neuroscience (Leiden, NL)
MSCA-DN PhD position in translational in vivo neuroscience (Leiden, NL)

SIGRA • Amsterdam

On-site
EUR 35,000 - 42,000
MSCA-DN PhD in gene correction for vanishing white matter & MLD (Zurich, CH)
MSCA-DN PhD in gene correction for vanishing white matter & MLD (Zurich, CH)

SIGRA • Amsterdam

On-site
EUR 32,000 - 42,000
MSCA-DN PhD in pharmacological therapy for leukodystrophies (Rome, IT)
MSCA-DN PhD in pharmacological therapy for leukodystrophies (Rome, IT)

SIGRA • Amsterdam

On-site
EUR 28,000 - 36,000
MSCA-DN PhD position in liquid biomarkers for leukodystrophies (Tübingen, GE)
MSCA-DN PhD position in liquid biomarkers for leukodystrophies (Tübingen, GE)

SIGRA • Amsterdam

On-site
EUR 42,000 - 52,000
PhD in Zebrafish Leukodystrophy: Translational Imaging
PhD in Zebrafish Leukodystrophy: Translational Imaging

SIGRA • Amsterdam

On-site
EUR 57,000 - 62,000
MSCA-DN PhD in regulatory & access pathways for leukodystrophy (Utrecht, NL)
MSCA-DN PhD in regulatory & access pathways for leukodystrophy (Utrecht, NL)

SIGRA • Amsterdam

On-site
EUR 23,000 - 30,000
MSCA-DN PhD in quality of life & resilience in leukodystrophy (Tübingen, GE)
MSCA-DN PhD in quality of life & resilience in leukodystrophy (Tübingen, GE)

SIGRA • Amsterdam

On-site
EUR 36,000 - 48,000
Salary according to MSCA rules
Mobility allowance
Network-wide training & secondments
+1
MSCA-DN PhD position in Gene Therapy for Leukodystrophies
MSCA-DN PhD position in Gene Therapy for Leukodystrophies

SIGRA • Amsterdam

On-site
EUR 36,000 - 45,000
Living allowance provided
Mobility allowance
Pension ABP contribution
+2